Humedix Co., Ltd. (KOSDAQ:200670)
South Korea · Delayed Price · Currency is KRW 26,150
-100 (-0.38%)
Aug 31, 2026, 3:30 PM KST
Humedix Revenue
In the year 2021, Humedix had annual revenue of 110.99B KRW with 12.70% growth. Humedix had revenue of 30.37B in the quarter ending December 31, 2021, a decrease of -13.10%.
Revenue
110.99B
Revenue Growth
+12.70%
P/S Ratio
2.43
Revenue / Employee
447.55M
Employees
248
Market Cap
269.87B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 110.99B | 12.51B | 12.70% |
| Dec 31, 2020 | 98.48B | 19.86B | 25.26% |
| Dec 31, 2019 | 78.62B | 13.79B | 21.27% |
| Dec 31, 2018 | 64.83B | 10.10B | 18.46% |
| Dec 31, 2017 | 54.73B | 7.59B | 16.11% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JW Holdings | 1.01T |
| Chong Kun Dang Holdings | 961.64B |
| Dong-A ST | 860.94B |
| Suheung | 765.90B |
| Huons | 616.80B |
| Samjin Pharmaceuticals | 274.03B |
| Whan In Pharm | 273.47B |
| Korea United Pharm | 161.44B |